James M. Thorburn - 08 Jun 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Financial Officer
Signature
/s/ William Solis, as Attorney-in-Fact for James M. Thorburn
Issuer symbol
TWST
Transactions as of
08 Jun 2021
Net transactions value
-$734,320
Form type
4
Filing time
10 Jun 2021, 16:30:44 UTC
Previous filing
02 Jun 2021
Next filing
06 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $92,720 +8,000 +17% $11.59 54,732 08 Jun 2021 Direct
transaction TWST Common Stock Sale $827,040 -8,000 -15% $103.38 46,732 08 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -8,000 -14% $0.000000 50,330 08 Jun 2021 Common Stock 8,000 $11.59 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 16, 2020.
F2 The option is immediately exercisable. 25% of the shares subject to the option vested on April 23, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.